10
Disclosures
Feb 13, 2026 — May 26, 2026
Date Range
GROWTH
Market Segment
Pharmaceutical
Sector
Disclosures
| Date | Type | Headline | |
|---|---|---|---|
| May 26 | Other | Cuorips Announces Board Changes Effective June 25 | |
| May 26 | Other | Cuorips to Move Headquarters and Amend Articles Amidst Business Expansion | |
| May 26 | Other | Cuorips Appoints New Auditor for Upcoming Shareholders Meeting | |
| Mar 6 | Other | Cuorips Secures Conditional Approval for iPSC-Derived Heart Cells Sheet | |
| Feb 19 | Other | Cuorips Receives Conditional Approval for IPSOC-1 Heart Cell Sheet | |
| Feb 13 | Other | Cuorips Set for Key Regulatory Meeting on IPSOC-1 Approval | |
| Feb 13 | Earnings | Cuorips Inc. reports Q3 non-operating income due to foreign exchange fluctuations | |
| Feb 13 | Forecast | Earnings Forecast Downward Revision | |
| Feb 13 | Earnings | Cuorips Inc. Reports Q3 FY2026 Earnings Presentation: Revenue of 207 million | |
| Feb 13 | Earnings | Cuorips Inc. Reports Q3 Revenue of 207 million, Up 674% |
Disclosure Types
Other: 6 Earnings: 3 Forecast: 1